CBT for PTSD in Disaster Relief Workers

认知行为疗法治疗救灾人员的创伤后应激障碍

基本信息

项目摘要

DESCRIPTION (provided by applicant): This Rapid application proposes to conduct a randomized controlled trial with 42 male or female New York City disaster relief workers exposed to the terrorist attack of September 11, 2001 and its aftermath who carry a primary diagnosis of full or subthreshold PTSD related to the event. One hundred and five workers will be included in the initial assessment for DSM-IV Axis I disorders and PTSD symptom status to allow for a 20 percent non-inclusion and 30 percent dropout rate. Subjects meeting inclusion criteria will be randomized to either a 5-session CBT treatment (CBT; N= 21) or treatment as usual condition (TAU; N= 21). The sites for treatment will be the New York Weill Medical Center of Cornell University, Manhattan and Westchester Campuses. Treatment adherence will be assessed by the study team utilizing instruments developed by the authors of the manual, modified for use with disaster relief workers. Participants assigned to the CBT condition will complete self-report questionnaires at the end of each session. Post-treatment clinical interviews will be administered after the completion of the 5-week trial, and self-report assessments will be administered post-treatment and at 3 months. The aims of this proposed study are: (1) to evaluate the efficacy of a 5 session manualized individual, cognitive behavioral treatment (CBT), adapted for use with disaster workers, compared to a treatment as usual (TAU) contrast group; (2) to prepare for a larger scale three group randomized controlled study of CBT, EMDR, and supportive counseling for emergency services personnel exposed to a variety of critical incidents; (3) to explore potential moderators of treatment response in the CBT group, including baseline anger, reports of dissociation during trauma exposure, and dissociation during prolonged imaginal exposure in treatment.
描述(由申请人提供):本快速申请建议进行

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles R. Marmar其他文献

Examination of Patient and Provider Satisfaction, Benefits, and Challenges with Psychiatric Outpatient and Hospital-Based Telehealth Treatment during the COVID-19 Pandemic
  • DOI:
    10.1007/s11126-025-10150-w
  • 发表时间:
    2025-04-24
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    Christina Marini;Margot H. Steinberg;Carly D. Miron;Matthew Irwin;Bryana L. Schantz;David L. Ginsberg;Charles R. Marmar;Naomi M. Simon;Paraskevi Noulas;Kristin L. Szuhany
  • 通讯作者:
    Kristin L. Szuhany

Charles R. Marmar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles R. Marmar', 18)}}的其他基金

Leveraging systems pharmacology to advance precision medicine for Gabapentin treatment of AUD
利用系统药理学推进加巴喷丁治疗 AUD 的精准医学
  • 批准号:
    10887866
  • 财政年份:
    2023
  • 资助金额:
    $ 22.24万
  • 项目类别:
Leveraging systems pharmacology to advance precision medicine for Gabapentin treatment of AUD
利用系统药理学推进加巴喷丁治疗 AUD 的精准医学
  • 批准号:
    10629306
  • 财政年份:
    2022
  • 资助金额:
    $ 22.24万
  • 项目类别:
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD
利用生物标志物对合并 PTSD 的酒精使用障碍进行个性化治疗
  • 批准号:
    10237280
  • 财政年份:
    2018
  • 资助金额:
    $ 22.24万
  • 项目类别:
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD
利用生物标志物对合并 PTSD 的酒精使用障碍进行个性化治疗
  • 批准号:
    10237281
  • 财政年份:
    2018
  • 资助金额:
    $ 22.24万
  • 项目类别:
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD
利用生物标志物对合并 PTSD 的酒精使用障碍进行个性化治疗
  • 批准号:
    10473674
  • 财政年份:
    2018
  • 资助金额:
    $ 22.24万
  • 项目类别:
Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD
利用生物标志物对合并 PTSD 的酒精使用障碍进行个性化治疗
  • 批准号:
    10473675
  • 财政年份:
    2018
  • 资助金额:
    $ 22.24万
  • 项目类别:
Cannabidiol as a treatment for alcohol use disorder comorbid with posttraumatic stress disorder
大麻二酚用于治疗伴有创伤后应激障碍的酒精使用障碍
  • 批准号:
    9436640
  • 财政年份:
    2017
  • 资助金额:
    $ 22.24万
  • 项目类别:
POSTTRAUMATIC STRESS IN POLICE OFFICERS
警官的创伤后压力
  • 批准号:
    2407399
  • 财政年份:
    1997
  • 资助金额:
    $ 22.24万
  • 项目类别:
POSTTRAUMATIC STRESS IN POLICE OFFICERS
警官的创伤后压力
  • 批准号:
    6433890
  • 财政年份:
    1997
  • 资助金额:
    $ 22.24万
  • 项目类别:
Prospective Study of Traumatic Stress in Police Officers
警务人员创伤应激的前瞻性研究
  • 批准号:
    7755356
  • 财政年份:
    1997
  • 资助金额:
    $ 22.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了